Z Gastroenterol 2019; 57(01): e56
DOI: 10.1055/s-0038-1677196
Georg Thieme Verlag KG Stuttgart · New York
Proliferation, migration and cell viability in hepatocellular carcinoma – what is the impact of IGFBP2?
E Backu
1
University Hospital Regensburg, Department of Internal Medicine I, Gastroenterology, Endocrinology, Rheumatology and Infectious diseases
,
E Aschenbrenner
1
University Hospital Regensburg, Department of Internal Medicine I, Gastroenterology, Endocrinology, Rheumatology and Infectious diseases
,
K Pollinger
1
University Hospital Regensburg, Department of Internal Medicine I, Gastroenterology, Endocrinology, Rheumatology and Infectious diseases
,
S Schlosser
1
University Hospital Regensburg, Department of Internal Medicine I, Gastroenterology, Endocrinology, Rheumatology and Infectious diseases
,
K Gülow
1
University Hospital Regensburg, Department of Internal Medicine I, Gastroenterology, Endocrinology, Rheumatology and Infectious diseases
,
C Kunst
1
University Hospital Regensburg, Department of Internal Medicine I, Gastroenterology, Endocrinology, Rheumatology and Infectious diseases
,
M Müller-Schilling
1
University Hospital Regensburg, Department of Internal Medicine I, Gastroenterology, Endocrinology, Rheumatology and Infectious diseases
› Author Affiliations
